Drug Profile
Sibrafiban
Alternative Names: RO 483657; RO 483657-000; XubixLatest Information Update: 20 Jul 2000
Price :
$50
*
At a glance
- Originator Genentech; Roche
- Class Antiplatelets; Ischaemic heart disorder therapies
- Mechanism of Action GPIIb-IIIa antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arterial thrombosis; Myocardial infarction; Unstable angina pectoris
Most Recent Events
- 20 Jul 2000 Discontinued-III for Arterial thrombosis in World (PO)
- 20 Jul 2000 Discontinued-III for Myocardial infarction in World (PO)
- 20 Jul 2000 Discontinued-III for Unstable angina pectoris in World (PO)